The antiglucocoticoid RU486 downregulates the expression of interleukin-2 receptors in normal human lymphocytes
- 31 December 1991
- journal article
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 39 (6) , 929-935
- https://doi.org/10.1016/0960-0760(91)90351-5
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Interleukin-2 Receptor β Chain Gene: Generation of Three Receptor Forms by Cloned Human α and β Chain cDNA'sScience, 1989
- The two-chain structure of high-affinity IL-2 receptorsImmunology Today, 1987
- Termination of Early Pregnancy by the Progesterone Antagonist RU 486 (Mifepristone)New England Journal of Medicine, 1986
- Differential Expression of the ?-Tubulin Multigene Family during Rat Brain DevelopmentAnnals of the New York Academy of Sciences, 1986
- Successful Treatment of Cushing’s Syndrome with the Glucocorticoid Antagonist RU 486*Journal of Clinical Endocrinology & Metabolism, 1985
- The Antiprogestin RU38 486: Receptor-Mediated ProgestinVersusAntiprogestin Actions Screened in Estrogen-Insensitive T47DCOHuman Breast Cancer Cells*Endocrinology, 1985
- Low and high affinity cellular receptors for interleukin 2. Implications for the level of Tac antigen.The Journal of Experimental Medicine, 1984
- Molecular cloning and expression of cDNAs for the human interleukin-2 receptorNature, 1984
- A technique for radiolabeling DNA restriction endonuclease fragments to high specific activityAnalytical Biochemistry, 1983
- LIGAND: A versatile computerized approach for characterization of ligand-binding systemsAnalytical Biochemistry, 1980